Bimagrumab + Semaglutide: Preserving Muscle While Losing Fat on GLP-1 Therapy
How combining bimagrumab (anti-myostatin) with semaglutide prevents lean mass loss during GLP-1-driven weight loss — dosing, evidence, and who qualifies.
Peptide Therapy
Bimagrumab + Semaglutide: Preserving Muscle While Losing Fat on GLP-1 Therapy. Part of the Peptide Therapy library by Dr. med. univ. Julian Douwes